Trial intelligence / Profile preview

Atorvastatin exposure and ventilator-associated pneumonia cohort study

ChiCTR1800017647Phase 4Recruiting

Sponsor
Shanghai General Hospital
Start
Aug 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of atorvastatin in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Shanghai General Hospital. Primary endpoint: Incidence of ventilator-associated pneumonia. Started Aug 2018; status: recruiting.

02

Drugs

atorvastatin
03

Conditions

ventilator-associated pneumonia (VAP)

Beyond the preview

Go deeper on ChiCTR1800017647.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800017647.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call